"DNA Methylation signatures in panic disorder".

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Panic disorder (PD) affects millions, disproportionately women, with unknown causes.
• Genetic and environmental factors are implicated in PD risk.
• Epigenetic modifications, like DNA methylation, may play a role in PD.

Purpose of the Study:

• To investigate epigenome-wide DNA methylation differences in medication-free panic disorder patients compared to healthy controls.
• To explore potential sex-specific epigenetic alterations in PD.
• To identify specific genes and pathways associated with PD through DNA methylation.

Main Methods:

• An epigenome-wide association study (EWAS) using the Infinium HumanMethylation450 BeadChip on whole blood DNA.
• Stratification by gender and replication in independent samples.
• Functional analysis of methylation changes on gene expression.

Main Results:

• A significant genome-wide association identified a hypermethylated CpG locus in the HECA gene enhancer region in female PD patients.
• This finding was replicated and validated through meta-analysis, showing improved significance.
• Methylation at this locus correlated with HECA mRNA expression in females, suggesting a functional link.
• Five other candidate genes (SGK1, FHIT, ADCYAP1, HTR1A, HTR2A) previously linked to PD or anxiety also showed differential DNA methylation.

Conclusions:

• The study identified potential sex-specific DNA methylation changes in the HECA gene associated with panic disorder.
• These findings suggest a possible role for HECA gene methylation in the pathogenesis of PD in females.
• Overall, PD is not associated with extensive DNA methylation changes in peripheral blood, indicating a complex etiology.